Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2005
08/04/2005US20050169899 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals
08/04/2005US20050169898 Fusion of dendritic cells and antigen presenting cells; immunotherapy for stimulating an immune system; hybride cells; genetic engineering
08/04/2005US20050169897 Engraftable neural progenitor and stem cells for brain tumor therapy
08/04/2005US20050169891 Tissue tropism of a virus capsid, of protein fragments from different viruses, adenovirus of subgroup C or subgroup B
08/04/2005US20050169888 Methods related to immunostimulatory nucleic acid-induced interferon
08/04/2005US20050169887 Method and pharmaceutical composition for treating inflammation
08/04/2005US20050169885 Recombinant super-compound interferon
08/04/2005US20050169884 Administering an hematopoietic colony stimulating factors of sargramostim; Crohn's Disease
08/04/2005US20050169882 Multi-functional polymeric materials and their uses
08/04/2005US20050169870 Methods of modulating CD200
08/04/2005US20050169853 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with Porphyromonas gingivalis
08/04/2005CA2554330A1 Apparatus and methods for enzymatic debridement of skin lesions
08/04/2005CA2554234A1 Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages
08/04/2005CA2553986A1 Adjuvant compositions
08/04/2005CA2553871A1 Smac peptidomimetics and the uses thereof
08/04/2005CA2553845A1 A method of modulating pro-inflammatory and inflammatory activity mediated by c-reactive protein
08/04/2005CA2553541A1 Chimpanzee adenovirus vaccine carriers
08/04/2005CA2553221A1 Folate conjugates and complexes
08/04/2005CA2552894A1 Methods of using high affinity atiii variants
08/04/2005CA2552892A1 O-linked glycosylation of peptides
08/04/2005CA2552758A1 Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
08/04/2005CA2552757A1 Methods of using cgrp for cardiovascular and renal indications
08/04/2005CA2552754A1 Frequency assisted transdermal agent delivery method and system
08/04/2005CA2552043A1 Transglutaminase mediated conjugation of peptides
08/04/2005CA2544495A1 Use of substances having oxytocin antagonistic properties for the preparation of a medicament for treating hypertension
08/03/2005EP1560025A2 Specific markers for diabetes
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1559724A1 Glp-1 derivatives and transmicosal absorption preparations thereof
08/03/2005EP1559723A1 A segment of glycosylation-deficient HGF alpha-chain
08/03/2005EP1559721A1 Novel fprl1 ligands and use thereof
08/03/2005EP1559438A1 Hemostatic compositions and devices
08/03/2005EP1559431A1 Pharmaceutical composition for thrombin peptide derivatives
08/03/2005EP1559424A2 The use of inhibitors of the renin-angiotensin system
08/03/2005EP1559420A1 Treatment of tinnitus
08/03/2005EP1559328A1 Fungal feeds for aquaculture and agriculture
08/03/2005EP1559327A1 Bacterial feeds for aquaculture and agriculture
08/03/2005EP1558766A2 Use of a33 antigens and jam-it
08/03/2005EP1558749A2 Atypical protein kinase c isoforms in disorders of the nervous system and cancer
08/03/2005EP1558747A2 Glycoprotein synthesis
08/03/2005EP1558737A1 Gene families associated with cancers
08/03/2005EP1558736A1 A method of modulating epithelial cell activity by modulating the functional levels of sphingosine kinase
08/03/2005EP1558729A2 Rapidly degraded reporter fusion proteins
08/03/2005EP1558728A2 Methods to identify agents modulating functions of polypeptide galnac-transferases, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
08/03/2005EP1558643A2 T cell receptor display
08/03/2005EP1558641A1 Crystals of insulin analogues and method for the production thereof
08/03/2005EP1558640A2 Trimeric binding proteins for trimeric cytokines
08/03/2005EP1558633A1 COMPOSITION FOR THE TREATMENT OF INFECTION BY i FLAVIVIRIDAE /i VIRUSES
08/03/2005EP1558632A1 Macrocyclic peptides active against the hepatitis c virus
08/03/2005EP1558630A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use
08/03/2005EP1558628A1 Antigenic peptides
08/03/2005EP1558291A2 rAAV-VECTORED RIBOZYME COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINAL DISEASES
08/03/2005EP1558287A2 Uses of human zven antagonists
08/03/2005EP1558279A1 Oral formulation of botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease
08/03/2005EP1558278A2 Production of homotrimeric fusion proteins
08/03/2005EP1558277A1 Treatment of inflammatory bowel disease
08/03/2005EP1558276A2 Flaviviris fusion inhibitors
08/03/2005EP1558275A2 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation
08/03/2005EP1558274A2 Methods for controlling proliferation of cells
08/03/2005EP1558273A2 Treatment and prevention of pulmonary conditions
08/03/2005EP1558269A2 Botulinum toxin formulations for oral administration
08/03/2005EP1558251A1 Method of treatment of psychological conditions by administration of nerve growth factor
08/03/2005EP1558237A2 Improved glycemic control for prediabetes and/or diabetes type ii using docosahexaenoic acid
08/03/2005EP1558224A1 Process for the production of nanoparticles, wherein low mechanical and sonic energies are used simultaneously
08/03/2005EP1558085A1 Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer
08/03/2005EP1558080A2 Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor
08/03/2005EP1507860A4 Dynamic action reference tools
08/03/2005EP1418937A4 Enhancing organ maturity in neonates and predicting their duration of intensive care
08/03/2005EP1392347B1 Preventing cell death using segments of neural thread proteins
08/03/2005EP1368050A4 Virus derived antimicrobial peptides
08/03/2005EP1359975A4 Ocular iontophoretic device and method of use
08/03/2005EP1330166B1 Food grade transglutaminase inhibitor and uses thereof
08/03/2005EP1282438B1 Use of pharmaceutical composition comprising a factor viia and a factor xiii
08/03/2005EP1280895B1 Polypeptide inhibiting a proton-gated na+ channel
08/03/2005EP1267899B1 Ssa inactivated salmonella vaccines
08/03/2005EP1237900A4 Subunit optimized fusion proteins
08/03/2005EP1237567B1 Method for administering a cytokine to the central nervous system and the lymphatic system
08/03/2005EP1196439B1 Compounds exhibiting an antibiotic activity
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1140106B1 Treatment of diseases involving cyst formation
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
08/03/2005EP1049777B1 Acpl dna and polypeptides
08/03/2005EP1012285B1 Beta-defensins
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0896620B1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein
08/03/2005EP0851925B1 Human growth hormone variants
08/03/2005EP0825259B1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
08/03/2005EP0707596B1 Polymer-peptide conjugates
08/03/2005EP0702722B1 Plasmids suitable for gene therapy
08/03/2005EP0702719B1 Process for the sterilization of biological compositions and the product produced thereby
08/03/2005CN1650033A Genomic screen for epigenetically silenced genes associated with cancer
08/03/2005CN1650024A Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels
08/03/2005CN1650015A DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
08/03/2005CN1650012A Antigens encoded by alternative reading frame from pathogenic viruses
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1650005A Antimicrobial polypeptide and utizliation thereof
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
1 ... 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 ... 3163